2Bodner LM, Wisner KL. Implications for improving mental health among childbearing-aged women. Biological Psychiatry 2005; 58: 679–685.
3Reynolds EH, Preece JM, Bailey J, Coppen A. Folate deficiency in depressive illness. British Journal of Psychiatry 1970; 117: 287–292.
4Carney MWP, Chary TKN, Laundy M, Bottiglieri T, Chanarin I, Reynolds EH, et al. . Red cell folate concentrations in psychiatric patients. Journal of Affective Disorders 1990; 19: 207–213.
5Ghadirian AM, Anath J, Engelsmann F. Folic acid deficiency in depression. Psychosomatics 1980; 21: 926–929.
6Abouh-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatrica Scandinavica 1989; 80: 78–82.
7Coppen A, Abouh-Saleh MT. Plasma folate and affective morbidity during long-term lithium therapy. British Journal of Psychiatry 1982; 141: 87–89.
8Botez MI, Botez T, Levielle J, Biellmann P, Cadotte M. Neuropsychological correlates of folic acid deficiency: facts and hypotheses. In: Botez MI, Reynolds EH, eds. Folic Acid in Neurology, Psychiatry, and Internal Medicine. New York: Raven Press, 1979; 425–461.
9Guaraldi G, Fava M, Mazzi F, LaGreca P. An open trial of methyltetrahydrofolate (MTHF) in elderly depressed patients. Annals of Clinical Psychiatry 1993; 5: 101.
10Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. American Journal of Psychiatry 1997; 154: 426–428.
11Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. British Medical Journal 2002; 325: 1202–1209.
12Reynolds EH, Carney MWP. Methylation and mood. Lancet 1984; 2: 196–198.
13Cantoni GL. S-adenosylmethionine: a new intermediate formed enzymatically from l-methionine and adenosine triphosphate. Journal of Biological Chemistry 1953; 204: 403–416.
14Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademethionine (S-adenosylmethionine) in neurological disorders. Drugs 1994; 48: 137–152.
15Ordonez LA, Wurtman RJ. Folic acid deficiency and methyl group metabolism in rat brain: effects of l-Dopa. Archives of Biochemistry and Biophysics 1974; 160: 372–376.
16Agnoli A, Ruggieri S, Cerrone GG. The dopamine hypotheses of depression: results of treatment with dopaminergic drugs. In: Grattini S, ed. Depressive Disorders. Stuttgart: FK Schatauer Verlag, 1977; 447–458.
17Lapin IP, Oxenkrug GF. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969; 1: 132–136.
18Le Quan-Bui KH, Plaisant O, Leboyer M, Gay C, Kamal L, Devynck M, et al. . Reduced platelet serotonin in depression. Psychiatry Research 1984; 13: 129–139.
19Quintana J. Platelet serotonin and plasma tryptophan in endogenous depression. Clinical, therapeutic, and biological correlations. Journal of Affective Disorders 1992; 24: 55–62.
20Coppen AP, Turner P, Rowsell AR, Padgham C. 5-Hydroxytryptamine (5-HT) in the whole blood of patients with depressive illness. Postgraduate Medical Journal 1956; 52: 156–158.
21Botez MI, Young SN, Bachevalier J, Gauthier S. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxindoleacetic acid in human cerebrospinal fluid. Annals of Neurology 1982; 12: 479–484.
22Brattstrom L, Israellson B, Jeppson J, Hultberg B. Folic acid – an innocuous means to reduce plasma homocysteine. Scandinavian Journal of Clinical and Laboratory Investigation 1998; 48: 215–221.
23Bottiglieri T. Homocysteine and folate metabolism in depression. Progress in Neuro-psychopharmacology and Biological Psychiatry 2005; 29: 1103–1112.
24Homocysteine Lowering Trialists Collaboration. Dose dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. American Journal of Clinical Nutrition 2005; 82: 806–812.
25Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, et al. . A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111–113.
26Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al. . Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349: 1591–1593.
27Lewis SJ, Lawlor DA, Smith GD, Araya R, Timpson N, Day INM, et al. . The thermolabile variant of MTHFR is associated with depression in the British Women’s Heart and Health Study and a meta-analysis. Molecular Psychiatry 2006; 11: 352–360.
28Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C–T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Archives of General Psychiatry 2003; 60: 618–626.
29Bottiglieri T, Laundy M, Crellin R, Toone BK. Homocysteine, folate, methylation, and monoamine metabolism in depression. Journal of Neurology and Psychiatry 2000; 69: 228–234.
30Cassidy K, Kotynia-English R, Acres J, Flicker L, Lautenschlager NT, Almeida OP. Association between lifestyle factors and mental health measures among community-dwelling older women. Australian and New Zealand Journal of Psychiatry 2004; 38: 940–947.
31Bryan J, Calvaresi E, Hughes D. Short-term folate, vitamin B12 or vitamin B6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition 2002; 132: 1345–1356.
32Williams E, Stewart-Knox B, Bradbury I, Rowland I, Pentieva K, Helander A, et al. . Effect of folic acid supplementation and serotonin response in healthy males. British Journal of Nutrition 2005; 94: 602–608.
33Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods in Enzymology 1997; 281: 43–53.
34Almeida OP, Flicker L, Lautenschlager NT, Leedman P, Vasikaran S, van Bockxmeer FM. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiology of Aging 2005; 26: 251–257.
35Office for National Statistics. The National Statistics Socio-Economic Classification User Manual. London: HMSO, 2002.
36Farber ML. Time perspective and feeling tone a study in perception of the day. Journal of Psychology 1953; 35: 253–257.
37Larsen RJ, Kasimatis M. Individual differences in entrainment of mood to the weekly calendar. Journal of Personality and Social Psychology 1990; 58: 164–171.
38Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx Analyzer. Clinical Chemistry 1999; 45: 569–571.
39Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. Journal of Personality and Social Psychology 1988; 54: 1063–1070.
40Watson D. Mood and Temperament. New York: The Guilford Press, 2000.
41Williams E, Stewart-Knox B, Helander A, McConville C, Bradbury I, Rowland I. Associations between whole-blood serotonin and subjective mood in healthy male volunteers. Biological Psychology 2005; 71: 171–174.
42Duffy ME, Stewart-Knox BJ, McConville C, Bradbury I, O’Connor J, Helander A, et al. . The relationship between whole-blood serotonin and subjective mood in apparently healthy postmenopausal women. Biological Psychology 2006; 73: 165–168.
43Nunnally JC. Psychometric Theory, 2nd ed. New Delhi: McGraw Hill Ltd, 1981.
44Reynolds EH, Preece J, Johnson AL. Folate metabolism in epileptic and psychiatric patients. Journal of Neurology and Psychiatry 1971; 34: 726–732.
45Godfrey PSA, Toone BK, Carney MWP, Flynn TG, Bottiglieri T, Laundy M, et al. . Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336: 392–395.
46McConville C. Personality, motivational and situational influences on mood variability. Doctoral thesis, University of Ulster, Northern Ireland, 1992.
47Costello J, Benjamin R, Angold A, Silver D. Mood variability in adolescents. A study of depressed, nondepressed and comorbid patients. Journal of Affective Disorders 1991; 23: 199–212.
48McConville C, Cooper C. Mood variability and the intensity of depressive states. Current Psychology 1996; 14: 329–338.
49Beck AT, Ward CH, Mendelsohn M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961; 4: 561–571.
50Lubin B. Depression Adjective Checklist. San Diego, CA: Educational and Industrial Testing Service, 1981.
51Tellegen A. Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report. In: Tuma AH, Maser JD, eds. Anxiety and the Anxiety Disorders. Hillside, NJ: Erlbaum, 1985; 681–706.
52Sauberlich HE. Relationship of vitamin B-6, vitamin B-12, and folate to neurological and neuropsychiatric disorders. In: Bendich A, Butterworth C, eds. Micronutrients in Health and Disease Prevention. New York: Marcel Dekker, 1991: 187–218.
53Scientific Advisory Committee on Nutrition (SACN). Draft Report for Consultation: Folate and Disease Prevention. London: SACN, November 2005.
54Wald N. Prevention of neural tube defects – results of the Medical Research Council vitamin study. Lancet 1991; 338: 131–137.